DE69805981T2 - Erythromycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel - Google Patents

Erythromycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Info

Publication number
DE69805981T2
DE69805981T2 DE69805981T DE69805981T DE69805981T2 DE 69805981 T2 DE69805981 T2 DE 69805981T2 DE 69805981 T DE69805981 T DE 69805981T DE 69805981 T DE69805981 T DE 69805981T DE 69805981 T2 DE69805981 T2 DE 69805981T2
Authority
DE
Germany
Prior art keywords
production
medicinal products
nar
formula
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69805981T
Other languages
English (en)
Other versions
DE69805981D1 (de
Inventor
Constantin Agouridas
Jean-Francois Chantot
Alexis Denis
Claude Fromentin
Jean-Marie Pejac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Publication of DE69805981D1 publication Critical patent/DE69805981D1/de
Application granted granted Critical
Publication of DE69805981T2 publication Critical patent/DE69805981T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE69805981T 1997-02-27 1998-02-26 Erythromycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel Expired - Lifetime DE69805981T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9702352A FR2760017B1 (fr) 1997-02-27 1997-02-27 Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
PCT/FR1998/000378 WO1998038199A1 (fr) 1997-02-27 1998-02-26 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
DE69805981D1 DE69805981D1 (de) 2002-07-18
DE69805981T2 true DE69805981T2 (de) 2003-01-16

Family

ID=9504247

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69805981T Expired - Lifetime DE69805981T2 (de) 1997-02-27 1998-02-26 Erythromycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Country Status (21)

Country Link
EP (1) EP0968222B1 (de)
JP (1) JP4531136B2 (de)
KR (1) KR100529980B1 (de)
CN (1) CN1162442C (de)
AT (1) ATE219097T1 (de)
AU (1) AU728182B2 (de)
BR (1) BR9807795A (de)
CA (1) CA2282666C (de)
DE (1) DE69805981T2 (de)
DK (1) DK0968222T3 (de)
EA (1) EA002359B1 (de)
ES (1) ES2179475T3 (de)
FR (1) FR2760017B1 (de)
HU (1) HUP0001245A3 (de)
IL (1) IL131340A0 (de)
NO (1) NO315653B1 (de)
PL (1) PL187947B1 (de)
PT (1) PT968222E (de)
TR (1) TR199902092T2 (de)
WO (1) WO1998038199A1 (de)
ZA (1) ZA981482B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2782239A1 (fr) 1998-08-13 2000-02-18 Euromark Benne a racleur integre pour la distribution de produits destines a l'elevage
WO2000017218A1 (en) 1998-09-22 2000-03-30 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
BR9916969A (pt) 1999-01-27 2001-11-06 Pfizer Prod Inc Antibióticos cetólidos
WO2000063224A2 (en) * 1999-04-16 2000-10-26 Kosan Biosciences, Inc. Macrolide antiinfective agents
IL145739A0 (en) 1999-05-24 2002-07-25 Pfizer Prod Inc 13-methyl-erythromycin derivatives
ID27331A (id) * 1999-09-29 2001-03-29 Pfizer Prod Inc Pembuatan antibiotik-antibiotik ketolida karbamat
US6673774B2 (en) 2001-12-03 2004-01-06 Enanta Pharmaceuticals, Inc. 11-O-substituted macrolides and their descladinose derivatives
US6670331B2 (en) 2001-12-04 2003-12-30 Enanta Pharmaceuticals, Inc. 11-O-substituted ketolide derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2473525A1 (fr) * 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2718450B1 (fr) * 1994-04-08 1997-01-10 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
BR9807795A (pt) 2000-02-15
CN1162442C (zh) 2004-08-18
CN1248261A (zh) 2000-03-22
TR199902092T2 (xx) 2000-05-22
IL131340A0 (en) 2001-01-28
EP0968222A1 (de) 2000-01-05
CA2282666C (fr) 2008-09-02
AU728182B2 (en) 2001-01-04
KR100529980B1 (ko) 2005-11-22
PL335375A1 (en) 2000-04-25
AU6734798A (en) 1998-09-18
ZA981482B (en) 1999-02-23
KR20000075722A (ko) 2000-12-26
JP2001513101A (ja) 2001-08-28
NO315653B1 (no) 2003-10-06
JP4531136B2 (ja) 2010-08-25
EA199900765A1 (ru) 2000-04-24
ES2179475T3 (es) 2003-01-16
DE69805981D1 (de) 2002-07-18
HUP0001245A3 (en) 2003-05-28
EA002359B1 (ru) 2002-04-25
HUP0001245A1 (hu) 2000-09-28
NO994150L (no) 1999-08-27
NO994150D0 (no) 1999-08-27
PT968222E (pt) 2002-10-31
FR2760017A1 (fr) 1998-08-28
EP0968222B1 (de) 2002-06-12
WO1998038199A1 (fr) 1998-09-03
FR2760017B1 (fr) 1999-04-30
ATE219097T1 (de) 2002-06-15
CA2282666A1 (fr) 1998-09-03
PL187947B1 (pl) 2004-11-30
DK0968222T3 (da) 2002-10-07

Similar Documents

Publication Publication Date Title
BG100946A (en) New amino acid derivatives, method for their preparation and pharmaceutical compositions containing them
MY140677A (en) Modified amino acids, pharmaceuticals containing these compounds and method for their production
ATE219499T1 (de) Lipopeptid-derivate, verfahren zu ihrer herstellung und ihre verwendung
NO990227L (no) Heterocykliske forbindelser som farmas°ytika
TW200613290A (en) Substituted urea compounds
MX9803954A (es) Derivados de aminoacidos, composiciones farmaceuticas que contienen estos compuestos y procesos para prepararlos.
EA199901016A1 (ru) 9-оксим-производные эритромицина
ATE211474T1 (de) Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente
DE69805981T2 (de) Erythromycin-derivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE19776T1 (de) Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
DE60333546D1 (de) PyrazoloÄ4,3-DÜpyrimidines, verfahren zur ihre herstellung und deren verwendung
CO4340625A1 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos
DE69330601T2 (de) Serotoninergische ergolin derivate
DE60130916D1 (de) Neue beta-lactamverbindungen und verfahren zu deren herstellung
ATE501158T1 (de) Neue 2-halogen-derivate von 5-o- desosaminylerythronolid a, verfahren zu deren herstellung sowie deren verwendung als arzneimittel
WO2000043375A3 (de) Substituierte arylheterocyclen
ATE211731T1 (de) Verfahren zur herstellung von aminophenylsulfonylharnstoffen und zwischenprodukte zu den verfahren
AP9901566A0 (en) Novel erythromycin derivatives, method of preparation and application as medicines.
ATE165364T1 (de) Neue kardioaktive 17-iminomethylalkenyl-5-beta-14-beta-androstan und 17-iminoalkyl-5-beta, 14-beta- androstan derivate, ein verfahren zu ihrer herstellung und pharmazeutische präparate davon
ATE221889T1 (de) Cephalosporin-derivate, verfahren zu ihrer herstellung und diese enthaltende antimikrobielle mittel
DE60308516D1 (de) Zwischenprodukte, verfahren für deren herstellung und deren gebrauch
DE59914314D1 (de) 2,3,3a,4,9,9a-HEXAHYDRO-8-HYDROXY-1H-BENZÄFÜINDOLE, VERFAHREN ZU IHRER HERSTELLUNG UND IHRE VERWENDUNG ALS ARZNEIMITTEL
DE60011473D1 (de) Diazepinecarboxamidderivate, verfahren zu ihrer herstellung ,ihre verwendung als arzneimittel, pharmazeutische zubereitungen und ihre verwendung
IT1213440B (it) 2-ditioalchil-diidropiridine, un metodo per la loro preparazione e composizioni farmaceutiche chele contengono.
DE50008905D1 (de) Polycyclische thiazol-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC